BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yeboah J, Bertoni AG, Herrington DM, Post WS, Burke GL. Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2011;58:140-146. [PMID: 21718910 DOI: 10.1016/j.jacc.2011.03.025] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Suthutvoravut U, Anothaisintawee T, Boonmanunt S, Pramyothin S, Chaithanasarn A, Reutrakul S, Thakkinstian A. Efficacy of time-restricted eating and behavioural economic interventions in reducing fasting plasma glucose, HbA1c and cardiometabolic risk factors compared with time-restricted eating alone or usual care in patients with impaired fasting glucose: protocol for an open-label randomised controlled trial. BMJ Open 2022;12:e058954. [PMID: 36127075 DOI: 10.1136/bmjopen-2021-058954] [Reference Citation Analysis]
2 Bliudzius A, Svaikeviciene K, Puronaite R, Kasiulevicius V. Physical Activity Evaluation Using Activity Trackers for Type 2 Diabetes Prevention in Patients with Prediabetes. Int J Environ Res Public Health 2022;19:8251. [PMID: 35886100 DOI: 10.3390/ijerph19148251] [Reference Citation Analysis]
3 Bashkinov RA, Batluk TI, Melnikov ES, Trubnikova MA, Arutyunov AG. Influence of metabolic disorders on the development of renal pathology. jour 2022;3:7-18. [DOI: 10.21886/2712-8156-2022-3-2-7-18] [Reference Citation Analysis]
4 Ahmad Fazil Q’A, Jamaludin UK. Prediction of Blood Glucose Level Based on Lipid Profile and Blood Pressure Using Multiple Linear Regression Model. Human-Centered Technology for a Better Tomorrow 2022. [DOI: 10.1007/978-981-16-4115-2_4] [Reference Citation Analysis]
5 Wang Y, Wang L, Su Y, Zhong L, Peng B. Prediction model for the onset risk of impaired fasting glucose: a 10-year longitudinal retrospective cohort health check-up study. BMC Endocr Disord 2021;21:211. [PMID: 34686184 DOI: 10.1186/s12902-021-00878-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 El Fatouhi D, Héritier H, Allémann C, Malisoux L, Laouali N, Riveline JP, Salathé M, Fagherazzi G. Associations between device-measured physical activity and glycemic control and variability indices under free-living condition. Diabetes Technol Ther 2021. [PMID: 34648353 DOI: 10.1089/dia.2021.0294] [Reference Citation Analysis]
7 Gandhi A, Masand V, Zaki MEA, Al-Hussain SA, Ghorbal AB, Chapolikar A. QSAR analysis of sodium glucose co-transporter 2 (SGLT2) inhibitors for anti-hyperglycaemic lead development. SAR QSAR Environ Res 2021;32:731-44. [PMID: 34494464 DOI: 10.1080/1062936X.2021.1971295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Slurink IAL, den Braver NR, Rutters F, Kupper N, Smeets T, Elders PJM, Beulens JWJ, Soedamah-Muthu SS. Dairy product consumption and incident prediabetes in Dutch middle-aged adults: the Hoorn Studies prospective cohort. Eur J Nutr 2021. [PMID: 34245355 DOI: 10.1007/s00394-021-02626-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Barbu E, Popescu MR, Popescu AC, Balanescu SM. Phenotyping the Prediabetic Population-A Closer Look at Intermediate Glucose Status and Cardiovascular Disease. Int J Mol Sci 2021;22:6864. [PMID: 34202289 DOI: 10.3390/ijms22136864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 van Herpt TTW, Ligthart S, Leening MJG, van Hoek M, Lieverse AG, Ikram MA, Sijbrands EJG, Dehghan A, Kavousi M. Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria. BMJ Open Diabetes Res Care 2020;8:e001529. [PMID: 33214188 DOI: 10.1136/bmjdrc-2020-001529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Święcicka-Klama A, Połtyn-Zaradna K, Szuba A, Zatońska K. The Natural Course of Impaired Fasting Glucose. Adv Exp Med Biol 2021;1324:41-50. [PMID: 32767267 DOI: 10.1007/5584_2020_571] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Jambi H, Enani S, Malibary M, Bahijri S, Eldakhakhny B, Al-Ahmadi J, Al Raddadi R, Ajabnoor G, Boraie A, Tuomilehto J. The Association Between Dietary Habits and Other Lifestyle Indicators and Dysglycemia in Saudi Adults Free of Previous Diagnosis of Diabetes. Nutr Metab Insights 2020;13:1178638820965258. [PMID: 33116569 DOI: 10.1177/1178638820965258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Liu X, Song Q, Wu S, Zhou W, Wang X. Prediabetes and risk for myocardial infarction by hypertension status in a Chinese population: a prospective cohort study. J Hypertens 2021;39:77-83. [PMID: 32868639 DOI: 10.1097/HJH.0000000000002607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Neeland IJ, Boone SC, Mook-Kanamori DO, Ayers C, Smit RAJ, Tzoulaki I, Karaman I, Boulange C, Vaidya D, Punjabi N, Allison M, Herrington DM, Jukema JW, Rosendaal FR, Lamb HJ, van Dijk KW, Greenland P, de Mutsert R. Metabolomics Profiling of Visceral Adipose Tissue: Results From MESA and the NEO Study. J Am Heart Assoc 2019;8:e010810. [PMID: 31017036 DOI: 10.1161/JAHA.118.010810] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
15 Gabriel R, Boukichou Abdelkader N, Acosta T, Gilis-Januszewska A, Gómez-Huelgas R, Makrilakis K, Kamenov Z, Paulweber B, Satman I, Djordjevic P, Alkandari A, Mitrakou A, Lalic N, Colagiuri S, Lindström J, Egido J, Natali A, Pastor JC, Teuschl Y, Lind M, Silva L, López-Ridaura R, Tuomilehto J; e-PREDICE Consortium. Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data. PLoS One 2020;15:e0231196. [PMID: 32282852 DOI: 10.1371/journal.pone.0231196] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
16 Rathi N, Whelton PK, Chertow GM, Cushman WC, Cheung AK, Wei G, Boucher R, Kimmel PL, Bress AP, Kramer HJ, Al-Marji C, Greene T, Beddhu S. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events. Am J Hypertens 2019;32:1170-7. [PMID: 31257407 DOI: 10.1093/ajh/hpz105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Hubbard D, Colantonio LD, Tanner RM, Carson AP, Sakhuja S, Jaeger BC, Carey RM, Cohen LP, Shimbo D, Butler M, Bertoni AG, Langford AT, Booth JN 3rd, Kalinowski J, Muntner P. Prediabetes and Risk for Cardiovascular Disease by Hypertension Status in Black Adults: The Jackson Heart Study. Diabetes Care 2019;42:2322-9. [PMID: 31591089 DOI: 10.2337/dc19-1074] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
18 Wasserman DH, Wang TJ, Brown NJ. The Vasculature in Prediabetes. Circ Res 2018;122:1135-50. [PMID: 29650631 DOI: 10.1161/CIRCRESAHA.118.311912] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 21.3] [Reference Citation Analysis]
19 Florentin M, Liberopoulos E, Elisaf MS, Tsimihodimos V. No effect of fenugreek, bergamot and olive leaf extract on glucose homeostasis in patients with prediabetes: a randomized double-blind placebo-controlled study. Arch Med Sci Atheroscler Dis 2019;4:e162-6. [PMID: 31448348 DOI: 10.5114/amsad.2019.86756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
20 Farhan S, Redfors B, Maehara A, Mcandrew T, Ben-yehuda O, De Bruyne B, Mehran R, Giustino G, Kirtane AJ, Serruys PW, Mintz GS, Stone GW. Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes. JACC: Cardiovascular Imaging 2019;12:733-41. [DOI: 10.1016/j.jcmg.2017.06.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
21 Mongraw-Chaffin M, Bertoni AG, Golden SH, Mathioudakis N, Sears DD, Szklo M, Anderson CAM. Association of Low Fasting Glucose and HbA1c With Cardiovascular Disease and Mortality: The MESA Study. J Endocr Soc 2019;3:892-901. [PMID: 31020054 DOI: 10.1210/js.2019-00033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Braga T, Kraemer-Aguiar LG, Docherty NG, Le Roux CW. Treating prediabetes: why and how should we do it? Minerva Med 2019;110:52-61. [PMID: 30371047 DOI: 10.23736/S0026-4806.18.05897-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
23 Richter B, Hemmingsen B, Metzendorf MI, Takwoingi Y. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.Cochrane Database Syst Rev. 2018;10:CD012661. [PMID: 30371961 DOI: 10.1002/14651858.CD012661.pub2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 57] [Article Influence: 8.5] [Reference Citation Analysis]
24 Stacey RB, Zgibor J, Leaverton PE, Schocken DD, Peregoy JA, Lyles MF, Bertoni AG, Burke GL. Abnormal Fasting Glucose Increases Risk of Unrecognized Myocardial Infarctions in an Elderly Cohort. J Am Geriatr Soc 2019;67:43-9. [PMID: 30298627 DOI: 10.1111/jgs.15604] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Tong YZ, Tong NW, Teng WP, Mu YM, Zhao JJ, Shan ZY, Ning G; Chinese Society of Endocrinology. Consensus on the Prevention of Type 2 Diabetes in Chinese Adults. Chin Med J (Engl) 2017;130:600-6. [PMID: 28229993 DOI: 10.4103/0366-6999.200532] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
26 Zhang W, Yang X, Han P, Ma Y, Fu L, Jia L, Yu H, Chen X, Wang L, Hou L, Yu X, Kohzuki M, Guo Q. Risk factors for developing diabetes after 3 years among community-dwelling elderly with impaired fasting glucose: Risk factors for developing diabetes. Journal of Diabetes 2019;11:107-14. [DOI: 10.1111/1753-0407.12816] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
27 Dell’oro R, Trevano FQ, Gamba P, Ciuffarella C, Seravalle G, Mancia G, Grassi G. Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state. Journal of Hypertension 2018;36:1195-200. [DOI: 10.1097/hjh.0000000000001659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
28 Guo VY, Yu EY, Wong CK, Sit RW, Wang JH, Lam CL. Hypertriglyceridaemic-waist phenotype and risk of diabetes in people with impaired fasting glucose in primary care: a cohort study. Diabet Med 2018;35:576-82. [PMID: 29438572 DOI: 10.1111/dme.13601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
29 Bertoni AG, Kramer H, Watson K, Post WS. Diabetes and Clinical and Subclinical CVD. Glob Heart 2016;11:337-42. [PMID: 27741980 DOI: 10.1016/j.gheart.2016.07.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
30 Cefalu WT. "Prediabetes": Are There Problems With This Label? No, We Need Heightened Awareness of This Condition! Diabetes Care 2016;39:1472-7. [PMID: 27457639 DOI: 10.2337/dc16-1143] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
31 de Abreu LLF, Holloway KL, Mohebbi M, Sajjad MA, Kotowicz MA, Pasco JA. All-Cause Mortality Risk in Australian Women with Impaired Fasting Glucose and Diabetes. J Diabetes Res 2017;2017:2042980. [PMID: 28698884 DOI: 10.1155/2017/2042980] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Chhetri JK, Zheng Z, Xu X, Ma C, Chan P. The prevalence and incidence of frailty in Pre-diabetic and diabetic community-dwelling older population: results from Beijing longitudinal study of aging II (BLSA-II). BMC Geriatr 2017;17:47. [PMID: 28178934 DOI: 10.1186/s12877-017-0439-y] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
33 Chhetri JK, Zheng Z, Xu X, Ma C, Chan P. The prevalence and incidence of frailty in Pre-diabetic and diabetic community-dwelling older population: results from Beijing longitudinal study of aging II (BLSA-II). BMC Geriatr 2017;17:47. [PMID: 28178934 DOI: 10.1186/s12877-017-0439-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Harumi Higuchi Dos Santos M, Sharma A, Sun JL, Pieper K, McMurray JJ, Holman RR, Lopes RD. International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial. J Am Heart Assoc 2017;6:e003892. [PMID: 28087508 DOI: 10.1161/JAHA.116.003892] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 Ibrahim N, Ming Moy F, Awalludin IA, Mohd Ali Z, Ismail IS. Effects of a Community-Based Healthy Lifestyle Intervention Program (Co-HELP) among Adults with Prediabetes in a Developing Country: A Quasi-Experimental Study. PLoS One 2016;11:e0167123. [PMID: 27935988 DOI: 10.1371/journal.pone.0167123] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
36 Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953. [PMID: 27881363 DOI: 10.1136/bmj.i5953] [Cited by in Crossref: 446] [Cited by in F6Publishing: 478] [Article Influence: 74.3] [Reference Citation Analysis]
37 Whelton SP, McEvoy JW, Lazo M, Coresh J, Ballantyne CM, Selvin E. High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study. Diabetes Care 2017;40:261-9. [PMID: 28108537 DOI: 10.2337/dc16-1541] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
38 Sitnik D, Santos IS, Goulart AC, Staniak HL, Manson JE, Lotufo PA, Bensenor IM. Fasting glucose levels, incident diabetes, subclinical atherosclerosis and cardiovascular events in apparently healthy adults: A 12-year longitudinal study. Diabetes and Vascular Disease Research 2016;13:429-37. [DOI: 10.1177/1479164116653356] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
39 Liu F, Yang X, Li J, Cao J, Chen J, Li Y, Liu X, Zhao L, Shen C, Yu L, Huang J, Gu D. Association of fasting glucose levels with incident atherosclerotic cardiovascular disease: An 8-year follow-up study in a Chinese population: 中国人群空腹血糖水平与动脉粥样硬化性心血管疾病发病的关系:一项为期8年的随访研究. J Diabetes 2017;9:14-23. [DOI: 10.1111/1753-0407.12380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
40 Kim HK, Lee JB, Kim SH, Jo MW, Kim EH, Hwang JY, Bae SJ, Jung CH, Lee WJ, Park JY, Park GM, Kim YH, Choe J. Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans. J Diabetes 2016;8:657-66. [PMID: 26355268 DOI: 10.1111/1753-0407.12343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
41 Xu T, Liu W, Cai X, Ding J, Tang H, Huang Y, Hu Y. Risk of Coronary Heart Disease in Different Criterion of Impaired Fasting Glucose: A Meta-Analysis. Medicine (Baltimore). 2015;94:e1740. [PMID: 26448033 DOI: 10.1097/md.0000000000001740] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
42 Shah RV, Allison MA, Lima JA, Abbasi SA, Eisman A, Lai C, Jerosch-Herold M, Budoff M, Murthy VL. Abdominal fat radiodensity, quantity and cardiometabolic risk: The Multi-Ethnic Study of Atherosclerosis. Nutr Metab Cardiovasc Dis 2016;26:114-22. [PMID: 26817938 DOI: 10.1016/j.numecd.2015.12.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
43 Ligthart S, van Herpt TT, Leening MJ, Kavousi M, Hofman A, Stricker BH, van Hoek M, Sijbrands EJ, Franco OH, Dehghan A. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol 2016;4:44-51. [PMID: 26575606 DOI: 10.1016/S2213-8587(15)00362-9] [Cited by in Crossref: 145] [Cited by in F6Publishing: 125] [Article Influence: 20.7] [Reference Citation Analysis]
44 Stacey RB, Leaverton PE, Schocken DD, Peregoy JA, Bertoni AG. Prediabetes and the association with unrecognized myocardial infarction in the multi-ethnic study of atherosclerosis. Am Heart J 2015;170:923-8. [PMID: 26542500 DOI: 10.1016/j.ahj.2015.08.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
45 Samaras K, Crawford J, Lutgers HL, Campbell LV, Baune BT, Lux O, Brodaty H, Trollor JN, Sachdev P. Metabolic Burden and Disease and Mortality Risk Associated with Impaired Fasting Glucose in Elderly Adults. J Am Geriatr Soc 2015;63:1435-42. [PMID: 26147402 DOI: 10.1111/jgs.13482] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
46 Aroda VR, Getaneh A. Guiding diabetes screening and prevention: rationale, recommendations and remaining challenges. Expert Rev Endocrinol Metab 2015;10:381-98. [PMID: 30293496 DOI: 10.1586/17446651.2015.1054280] [Reference Citation Analysis]
47 Ghody P, Shikha D, Karam J, Bahtiyar G. Identifying prediabetes – Is it beneficial in the long run? Maturitas 2015;81:282-6. [DOI: 10.1016/j.maturitas.2015.03.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
48 Abbasi SA, Hundley WG, Bluemke DA, Jerosch-Herold M, Blankstein R, Petersen SE, Rider OJ, Lima JA, Allison MA, Murthy VL, Shah RV. Visceral adiposity and left ventricular remodeling: The Multi-Ethnic Study of Atherosclerosis. Nutr Metab Cardiovasc Dis 2015;25:667-76. [PMID: 26033394 DOI: 10.1016/j.numecd.2015.03.016] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
49 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 242] [Cited by in F6Publishing: 256] [Article Influence: 34.6] [Reference Citation Analysis]
50 Shah RV, Allison MA, Lima JA, Abbasi SA, Mongraw-Chaffin M, Jerosch-Herold M, Ding J, Budoff MJ, Murthy VL. Liver steatosis and the risk of albuminuria: the multi-ethnic study of atherosclerosis. J Nephrol 2015;28:577-84. [PMID: 25712234 DOI: 10.1007/s40620-015-0177-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
51 Ajala O, English P. Dietary Management of Pre-Diabetes and Type 2 Diabetes. Glucose Intake and Utilization in Pre-Diabetes and Diabetes 2015. [DOI: 10.1016/b978-0-12-800093-9.00007-7] [Reference Citation Analysis]
52 Al-Rubeaan K, Al-Manaa HA, Khoja TA, Ahmad NA, Al-Sharqawi AH, Siddiqui K, Alnaqeb D, Aburisheh KH, Youssef AM, Al-Batel A, Alotaibi MS, Al-Gamdi AA. Epidemiology of abnormal glucose metabolism in a country facing its epidemic: SAUDI-DM study. J Diabetes 2015;7:622-32. [PMID: 25266306 DOI: 10.1111/1753-0407.12224] [Cited by in Crossref: 64] [Cited by in F6Publishing: 77] [Article Influence: 8.0] [Reference Citation Analysis]
53 Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB, Jerosch-Herold M, Lima JA, Ding J, Allison MA. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc Imaging 2014;7:1221-35. [PMID: 25440591 DOI: 10.1016/j.jcmg.2014.07.017] [Cited by in Crossref: 228] [Cited by in F6Publishing: 245] [Article Influence: 28.5] [Reference Citation Analysis]
54 Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine 2015;48:371-93. [PMID: 25294012 DOI: 10.1007/s12020-014-0436-2] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 11.1] [Reference Citation Analysis]
55 Huang Y, Cai X, Chen P, Mai W, Tang H, Huang Y, Hu Y. Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med. 2014;46:684-692. [PMID: 25230915 DOI: 10.3109/07853890.2014.955051] [Cited by in Crossref: 69] [Cited by in F6Publishing: 81] [Article Influence: 8.6] [Reference Citation Analysis]
56 Moore MJ, Gong Y, Hou W, Hall K, Schmidt SO, Curry RW Jr, Beitelshees AL, Chapman A, Turner ST, Schwartz GL, Bailey K, Boerwinkle E, Gums JG, Cooper-DeHoff RM, Johnson JA. Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide. Pharmacotherapy 2014;34:1132-40. [PMID: 25202885 DOI: 10.1002/phar.1483] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
57 Qin G, Lu L, Xiao Y, Zhu Y, Pan W, Xu X, Shen S, Das UN. A cross-sectional study of the relationship between serum liver enzymes level and the incidence of impaired fasting glucose in males and females. Med Sci Monit 2014;20:1319-25. [PMID: 25066107 DOI: 10.12659/MSM.890698] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
58 Shah RV, Murthy VL, Abbasi SA, Eng J, Wu C, Ouyang P, Kwong RY, Goldfine A, Bluemke DA, Lima J, Jerosch-Herold M. Weight loss and progressive left ventricular remodelling: The Multi-Ethnic Study of Atherosclerosis (MESA). Eur J Prev Cardiol 2015;22:1408-18. [PMID: 25009171 DOI: 10.1177/2047487314541731] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
59 Shah RV, Abbasi SA, Yamal JM, Davis BR, Barzilay J, Einhorn PT, Goldfine AB; ALLHAT Collaborative Research Group. Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real? J Clin Hypertens (Greenwich) 2014;16:451-8. [PMID: 24779706 DOI: 10.1111/jch.12325] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
60 Mogadam M. Do statins increase the risk of diabetes or is it guilt by association?: . Current Opinion in Endocrinology & Diabetes and Obesity 2014;21:140-5. [DOI: 10.1097/med.0000000000000050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
61 Ibrahim N, Moy FM, Awalludin IA, Ali Z, Ismail IS. The health-related quality of life among pre-diabetics and its association with body mass index and physical activity in a semi-urban community in Malaysia--a cross sectional study. BMC Public Health 2014;14:298. [PMID: 24684809 DOI: 10.1186/1471-2458-14-298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
62 Desai CS, Ning H, Kang J, Folsom AR, Polak JF, Sibley CT, Tracy R, Lloyd-Jones DM. Competing cardiovascular outcomes associated with subclinical atherosclerosis (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2013;111:1541-6. [PMID: 23499272 DOI: 10.1016/j.amjcard.2013.02.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
63 Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279-2290. [PMID: 22683128 DOI: 10.1016/s0140-6736(12)60283-9] [Cited by in Crossref: 1388] [Cited by in F6Publishing: 1478] [Article Influence: 138.8] [Reference Citation Analysis]
64 Lee M, Saver JL, Hong KS, Song S, Chang KH, Ovbiagele B. Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ. 2012;344:e3564. [PMID: 22677795 DOI: 10.1136/bmj.e3564] [Cited by in Crossref: 127] [Cited by in F6Publishing: 146] [Article Influence: 12.7] [Reference Citation Analysis]
65 Kuller LH. Metformin Use Among Individuals at Risk for Type 2 Diabetes. Curr Diab Rep 2012;12:265-73. [DOI: 10.1007/s11892-012-0263-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
66 Chatterjee S, Maitra S. Impaired Fasting Glucose and the Risk of Incident Diabetes Mellitus and Cardiovascular Events. Journal of the American College of Cardiology 2011;58:2546-7. [DOI: 10.1016/j.jacc.2011.07.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Yeboah J, Bertoni AG, Herrington DM, Post WS, Burke GL. Reply. Journal of the American College of Cardiology 2011;58:2547. [DOI: 10.1016/j.jacc.2011.08.049] [Reference Citation Analysis]